S
Sharon Funk
Researcher at Anschutz Medical Campus
Publications - 22
Citations - 3177
Sharon Funk is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Haemophilia & Hemarthrosis. The author has an hindex of 11, co-authored 20 publications receiving 2691 citations. Previous affiliations of Sharon Funk include University of Colorado Denver & University of Colorado Boulder.
Papers
More filters
Journal ArticleDOI
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J. Manco-Johnson,Marilyn J. Manco-Johnson,Thomas C. Abshire,Amy D. Shapiro,Brenda Riske,Michele R. Hacker,Ray F. Kilcoyne,J. David Ingram,M L Manco-Johnson,Sharon Funk,Linda J. Jacobson,Leonard A. Valentino,W. Keith Hoots,George R. Buchanan,Donna DiMichele,Michael Recht,Deborah L Brown,Cindy A. Leissinger,Shirley Bleak,Alan R. Cohen,Prasad Mathew,Alison Matsunaga,Desiree Medeiros,Diane J. Nugent,Gregory Thomas,Alexis A. Thompson,Kevin McRedmond,J. Michael Soucie,Harlan Austin,Bruce L. Evatt +29 more
TL;DR: Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A.
Journal ArticleDOI
Range of motion measurements: reference values and a database for comparison studies
TL;DR: Female subjects had greater joint mobility in all age groups in nearly all joints and the gender difference was most obvious in measures of ankle plantarflexion, elbow pronation and supination.
Journal ArticleDOI
Hemophilia joint health score reliability study
P. Hilliard,Sharon Funk,N. Zourikian,BM Bergstrom,C. S. Bradley,M. Mclimont,Marilyn J. Manco-Johnson,Pia Petrini,M. van den Berg,Brian M. Feldman +9 more
TL;DR: This study is the first in a series to assess the psychometric properties of the HJHS, a promising new measure of joint health in boys with haemophilia.
Journal ArticleDOI
Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.
Brian M. Feldman,Sharon Funk,Britt‐Marie Bergstrom,N. Zourikian,P. Hilliard,Janjaap van der Net,Raoul H.H. Engelbert,Pia Petrini,H. Marijke van den Berg,Marilyn J. Manco-Johnson,Georges E. Rivard,Audrey Abad,Victor S. Blanchette +12 more
TL;DR: The Hemophilia Joint Health Score was developed to be more sensitive for detecting arthropathy than the WFH physical examination scale, especially for children and those using factor prophylaxis.
Journal ArticleDOI
Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
Chengwen Li,Nattee Narkbunnam,Nattee Narkbunnam,Richard Jude Samulski,Aravind Asokan,Genlin Hu,L. J. Jacobson,M. J. Manco-Johnson,Paul E. Monahan,Marilyn J. Manco-Johnson,Brenda Riske,Ray F. Kilcoyne,M L Manco-Johnson,Sharon Funk,Linda J. Jacobson,J. David Ingram,Thomas C. Abshire,Thomas C. Abshire,Amy D. Shapiro,Michele R. Hacker,Leonard A. Valentino,W. Keith Hoots,Deborah L Brown,George R. Buchanan,Donna DiMichele,Michael Recht,Cindy A. Leissinger,Shirley Bleak,Alan R. Cohen,Prasad Mathew,Alison Matsunaga,Desiree Medeiros,Diane J. Nugent,Gregory Thomas,Alexis A. Thompson,Kevin McRedmond,J. Michael Soucie,Harlan Austin,Bruce L. Evatt +38 more
TL;DR: The results may guide rational design of clinical trials using alternative AAV serotypes and suggest that younger patients who are given AAV gene therapy will benefit from the lower prevalence of NAbs.